Ribosomal protein L13a pseudogene 2 (RPL13AP2)

RPL13AP2 encodes a pseudogene of ribosomal protein L13a. Unlike the protein-coding RPL13A gene, which is involved in ribosome structure and function as well as regulation of inflammatory processes, pseudogenes like RPL13AP2 do not encode functional proteins and are generally not implicated in therapeutic targeting or pharmacological intervention. RPL13AP2 exists due to the duplication and subsequent loss of function of the ancestral RPL13A gene—such processed pseudogenes are common in the human genome[1]. There is no evidence indicating a biological, pathological, or therapeutic role for RPL13AP2, and it should not be confused with the functional RPL13A gene. Key considerations: - RPL13AP2 is a pseudogene, not an active gene product or therapeutic target[1]. - Any research targeting "ribosomal protein L13a" usually refers to the functional gene (RPL13A), not its pseudogenes. - The canonical full name and abbreviation are as given above, but this entry is not an actionable drug or disease target, nor does it play a known role in molecular function or pathology. If your intention was to gather information about the functional ribosomal protein L13a (RPL13A), please clarify, as that gene is a structural constituent of the ribosome involved in protein synthesis and translational regulation, but that is distinct from RPL13AP2[4][7].

Other names

RPL13A_12_1359RPL13AP2